US Biosimilars See A Banner Year Despite Few Approvals

Multiple Products Compete On Key Molecules As Insulins Make Transition

2020 2021 dial speed
US biosimilar competition ramped up in 2020 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products